NPC(SH:600713) Zheng Quan Zhi Xing·2025-05-09 09:35Core Viewpoint - The Nomination and Human Resources Planning Committee of Nanjing Pharmaceutical Co., Ltd. has reviewed the qualifications of independent director candidates for the 10th Board of Directors and found them to meet the necessary legal and regulatory requirements [1][2]. Summary by Relevant Sections - The committee has evaluated the personal resumes and relevant materials of candidates Wang Chunhui, Lu Yindi, and Lü Wei, confirming that they possess the necessary educational background, work experience, and business capabilities to fulfill the responsibilities of independent directors [1]. - All candidates have participated in qualification training organized by the stock exchange and obtained the necessary certificates, demonstrating their understanding of the basic knowledge required for listed company operations [1]. - The independent director candidates do not hold shares in the company and have no other relationships with the company's directors, supervisors, senior management, or shareholders holding more than 5%, ensuring their independence [1]. - The candidates have not been subject to any disqualifications as per the Company Law, nor have they been banned from the securities market by the China Securities Regulatory Commission [1]. - The Nomination and Human Resources Planning Committee has agreed to nominate Wang Chunhui, Lu Yindi, and Lü Wei as independent director candidates for the 10th Board of Directors, to be submitted for the board's review [2].